Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.


CSE:QNTM - Post by User

Post by DavidRosenbergon Mar 19, 2023 8:31am
151 Views
Post# 35347397

Multiple sclerosis

Multiple sclerosis
Multiple sclerosis (MS) is a chronic autoimmune disease that affects the central nervous system (CNS), which includes the brain and spinal cord. In MS, the immune system mistakenly attacks the myelin sheath that covers nerve fibers in the CNS.
 
The myelin sheath is a protective layer that helps to insulate nerve fibers and allows for efficient transmission of electrical signals between neurons. When the myelin sheath is damaged, the nerve impulses are slowed down or blocked, which can lead to a range of neurological symptoms.
 
In MS, immune cells known as T-cells infiltrate the CNS and attack the myelin sheath. This triggers an inflammatory response that damages the myelin and leads to the formation of scar tissue (sclerosis). Over time, this damage can also affect the underlying nerve fibers, leading to permanent neurological damage.
 
The specific causes of MS are not fully understood, but it is thought to involve a combination of genetic and environmental factors. There is also evidence to suggest that viral infections may play a role in triggering the immune response that leads to myelin damage in MS.
 
Treatment for MS typically involves medications that suppress the immune system and reduce inflammation, as well as therapies to manage symptoms and promote function.
<< Previous
Bullboard Posts
Next >>